GlaxoSmithKline PLC Director/PDMR Shareholding (4071W)
April 16 2019 - 12:36PM
UK Regulatory
TIDMGSK
RNS Number : 4071W
GlaxoSmithKline PLC
16 April 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Mr B McNamara
=== ======================== ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 11
April 2019 on shares held in the Deferred
Annual Bonus Plan Post-Tax.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$40.8259 33.216
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-04-12
=== ======================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ======================== ===============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQQLFFKZFXBBL
(END) Dow Jones Newswires
April 16, 2019 12:36 ET (16:36 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024